Retinoic acid uses divergent mechanisms to activate or suppress mitogenesis in rat aortic smooth muscle cells

Journal of Clinical Investigation

Volumn 102, Issue 4, 1998, Pages 653-662

  Chen, Songcang ^a   Gardner, David G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell cycle; Extracellular signal regulated kinase; Mitogenesis; Rat aortic smooth muscle cells; Retinoic acid

Indexed keywords

RETINOIC ACID;

ANIMAL TISSUE; AORTA MEDIA; ARTICLE; CELL CYCLE; CONTROLLED STUDY; DNA SYNTHESIS; GROWTH STIMULATION; MITOGENESIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR DISEASE;

EID: 0032529067     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI3483     Document Type: Article

References (39)

1. Lammer, E.J., D.T. Chen, R.M. Hoar, N.D. Agnish, P.J. Benke, J.T. Braun, C.J. Curry, P.M. Fernhoff, A.W. Grix, I.T. Lott, et al. 1985. Retinoic acid embryopathy. N. Engl. J. Med. 313:837-841.
2. Sucov, H.M., E. Dyson, C.L. Gumeringer, J. Price, K.R. Chien, and R.M. Evans. 1994. RXRα mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev. 8:1007-1018.
3. Kastner, P., J.M. Grondona, M. Mark, A. Gansmuller, M. LeMeur, D. Deimo, J.L. Vonesch, P. Dolle, and P. Chambon. 1994. Genetic analysis of RXR alpha developmental function: convergence of RXR and RAR signaling pathways in heart and eye morphogenesis. Cell. 78:987-1003.
4. Mendelsohn, C., D. Lohnes, D. Decimo, T. Lufkin, M. LeMeur, P. Chambon, and M. Mark. 1994. Function of the retinoic acid receptors (RARs) during development. Development. 120:2749-2771.
5. Dyson, E., H.M. Sucov, S.W. Kubalak, G.W. Schmid-Schonbein, F.A. DeLano, R.M. Evans, J. Ross, Jr., and K.R. Chien. 1995. Atrial-like phenotype is associated with embryonic ventricular failure in retinoid X receptor α -/-mice. Proc. Natl. Acad. Sci. USA. 92:7386-7390.
6. Gruber, P.J., S.W. Kubalak, T. Pexieder, H.M. Sucov, R.M. Evans, and K.R. Chien. 1996. RXR alpha deficiency confers genetic susceptibility for aortic sac, conotruncal, atrioventricular cushion and ventricular muscle defects in mice. J. Clin. Invest. 98:1332-1343.
7. 3 and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J. Clin. Invest. 97:1577-1588.
8. Zhou, M.D., H.M. Sucov, R.M. Evans, and K.R. Chien. 1995 Retinoid-dependent pathways suppress myocardial cell hypertrophy. Proc. Natl. Acad. Sci. USA. 92:7391-7395.
9. Miano, J.M., S. Topouzis, M.J. Majesky, and E.N. Olson. 1996. Retinoid receptor expression and all-trans retinoic acid-mediated growth inhibition in vascular smooth muscle cells. Circulation. 93:1886-1895.
10. Warrell, R.P. Jr., H. de The, Z.Y. Wang, and L. Degos. 1993. Acute promyelocytic leukemia. N. Engl. J. Med. 329:177-189.
11. Esgleyes-Ribot, T., R.A. Chandraratna, D.A. Lew-Kaya, J. Sefton, and M. Duvic. 1994. Response of psoriasis to a new topical retinoid, AGN 190168. J. Am. Acad. Dermatol. 30:581-590.
12. Langenfeld, J., H. Kiyokawa, D. Sekula, J. Boyle, and E. Dmitrovsky. 1997. Posttranslational regulation of cyclin D1 by retinoic acid: A chemoprevention mechanism. Proc. Natl. Acad. Sci. USA. 94:12070-12074.
13. Zhou, Q., M. Stetler-Stevenson, and P.S. Steeg. 1997. Inhibition of cyclin D expression in human breast carcinoma cells by retinoids in vitro. Oncogene. 15:107-115.
14. Naka, K., H. Yokozaki, T. Domen, K. Hayashi, H. Kuniyasu, W. Yasui, R. Lotan, and E. Tahara. 1997. Growth inhibition of cultured human gastric cancer cells by 9-cis-retinoic acid with induction of cdk inhibitor Waf1/Cip1/ Sdi1/p21 protein. Differentiation. 61:313-320.
15. Waf1/Cip1 gene by retinoic acid receptor. J. Biol. Chem. 271: 31723-31728.
16. Babajko, S., and M. Binoux. 1996. Modulation by retinoic acid of insulin-like growth factor (IGF) and IGF binding protein expression in human SK-N-SH neuroblastoma cells. Eur. J. Endocrinol. 134:474-480.
17. Standeven, A.M., M. Escobar, R.L. Beard, Y.D. Yuan, and R.A. Chandraratna. 1997. Mitogenic effect of retinoid X receptor agonists in rat liver. Biochem. Pharmacol. 54:517-524.
18. Kastner, P., M. Mark, and P. Chambon. 1995. Nonsteroid nuclear receptors: What are genetic studies telling us about their role in real life? Cell. 83: 854-869.
19. Heyman, R.A., D.J. Mangelsdorf, J.A. Dyck, R.B. Stein, G. Eichele, R.M. Evans, and C. Thaller. 1992. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell. 68:397-406.
20. Bauer, R.F., L.O. Arthur, and D.L. Fine. 1976. Propagation of mouse mammary tumor cell lines and production of mouse mammary tumor virus in serum free medium. In Vitro. 12:558-563.
21. Matsushime, H., M.F. Roussel, R.A. Ashmun, and C.J. Sherr. 1991. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell. 65:701-713.
22. Fort, P., L. Marty, M. Piechaczyk, S.E. Sabrouty, C. Dani, P. Jeanteur, and J.M. Blanchard. 1985. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate dehydrogenase multigenic family. Nucleic Acids Res. 13:1431-1442.
23. Cao, L., J. Wu, and D.G. Gardner. 1995. Atrial natriuretic peptide suppresses the transcription of its guanylyl cyclase-linked receptor. J. Biol. Chem. 270:24891-24897.
24. 3 modulates growth of vascular smooth muscle cells. J. Clin. Invest. 87: 1889-1895.
25. Fujitani, Y., H. Ninomiya, T. Okada, Y. Urade, and T. Masaki. 1995. Suppression of endothelin-1-induced mitogenic responses of human aortic smooth muscle cells by interleukin-1 beta. J. Clin. Invest. 95:2474-2482.
26. Masood, I., K.E. Porter, and N.J. London. 1997. Endothelin-1 is a mediator of intimal hyperplasia in organ culture of human saphenous vein. Br. J. Surg. 84:499-503.
27. 2+ and protein kinase C in endothelin-stimulated Rat-1 cells. Biochem. J. 321:795-804.
28. Waskiewicz, A.J., and J.A. Cooper. 1995. Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr. Opin. Cell Biol. 7:798-805.
29. Sherr, C.J. 1996. Cancer cell cycles. Science. 274:1672-1677.
30. Teixeira, C., and M.A.C. Pratt. 1997. CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells. Mol. Endocrinol. 11:1191-1202.
31. Kawa, S., T. Nikaido, Y. Aoki, Y. Zhai, T. Kumagaya, K. Furihata, S. Fujii, and K. Kiyosawa. 1997. Arotinoid mofarotene (RO40-8757) up-regulates p21 and p27 during growth inhibition of pancreatic cancer cell lines. Int. J. Cancer. 72:906-911.
32. Owens, G.K. 1995. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75:487-517.
33. Colbert, M.C., D.G. Hall, T.R. Kimball, S.A. Witt, J.N. Lorenz, M.L. Kirby, T.E. Hewett, R. Klevitsky, and J. Robbins. 1997. Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice. J. Clin. Invest. 100:1958-1968.
34. Weber, H., M.L. Webb, R. Serafino, D.S. Taylor, S. Moreland, J. Norman, and C.J. Molloy. 1994. Endothelin-1 and angiotensin-II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: Evidence for common signaling mechanisms. Mol. Endocrinol. 8:148-158.
35. Morey, A.K., A. Pedram, M. Razandi, B.A. Prins, R.M. Hu, E. Biesiada, and E.R. Levin. 1997. Estrogen and progesterone inhibit vascular smooth muscle proliferation. Endocrinology. 138:3330-3339.
36. ras. Am. J. Physiol. 272:C2019-C2030.
37. Irons, C.E., M.A. Flynn, L.M. Mok, and E.E. Reynolds. 1996. Endothelin and PDGF enhance arachidonic acid release and DNA synthesis in vascular smooth muscle cells. Am. J. Physiol. 270:C1642-C1646.
38. Whelchel, A., J. Evans, and J. Posada. 1997. Inhibition of ERK activation attenuates endothelin-stimulated airway smooth muscle cell proliferation. Am. J. Resp. Cell Mol. Biol. 6:589-596.
39. Shim, J., H. Lee, J. Park, H. Kim, and E.-J. Choi. 1996. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature. 381:804-807.